Alegre, John Mark Y.

HRN: 28-69-98  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CEFUROXIME 750MG (VIAL)
03/17/2026
03/24/2026
IV
420mg
Q8
AGE URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTIIntra-abdominal    Compliance to guidelines: